CG Oncology, Inc. (CGON)
NASDAQ: CGON · Real-Time Price · USD
56.99
-1.35 (-2.31%)
At close: Feb 25, 2026, 4:00 PM EST
56.10
-0.89 (-1.56%)
After-hours: Feb 25, 2026, 4:55 PM EST
CG Oncology Market Cap
CG Oncology has a market cap or net worth of $4.6 billion as of February 25, 2026. Its market cap has increased by 109.02% in one year.
Market Cap
4.60B
Enterprise Value
3.92B
1-Year Change
109.02%
Ranking
Category
Stock Price
$56.99
Market Cap Chart
Since the IPO on January 25, 2024, CG Oncology's market cap has increased from $1.21B to $4.60B, an increase of 281.14%. That is a compound annual growth rate of 89.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 24, 2026 | 4.71B | 40.51% |
| Dec 31, 2025 | 3.35B | 53.40% |
| Dec 31, 2024 | 2.18B | 81.02% |
| Jan 25, 2024 | 1.21B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caris Life Sciences | 5.18B |
| Celcuity | 5.00B |
| Scholar Rock Holding | 4.79B |
| Apogee Therapeutics | 4.78B |
| Structure Therapeutics | 4.61B |
| Terns Pharmaceuticals | 4.52B |
| Amicus Therapeutics | 4.50B |
| Crinetics Pharmaceuticals | 4.47B |